Sort by
Refine Your Search
-
Listed
-
Employer
-
Field
-
with the Danish Confederation of Professional Associations. The allowance will be agreed upon with the relevant union. The period of employment is 3 years. You can read more about career paths at DTU
-
Confederation of Professional Associations. The allowance will be agreed upon with the relevant union. The period of employment is 2 years. The starting date is flexible and preferred to be as soon as possible
-
agreed upon with the relevant union. The period of employment is 2 years. You can read more about career paths at DTU here . Further information Further information may be obtained from Thomas Crouzier
-
. The allowance will be agreed upon with the relevant union. The period of employment is 2 years. You can read more about career paths at DTU here . Further information Further information may be obtained from
-
agreed upon with the relevant union. The period of employment is for 2 years starting from August 1st, or as soon as possible thereafter. You can read more about career paths at DTU here . Further
-
The appointment will be based on the collective agreement with the Danish Confederation of Professional Associations. The allowance will be agreed upon with the relevant union. The period of employment is 3 years
-
machine learning methods, including symbolic regression and neural networks. You will apply the algorithms to the discovery of new models in different fields, including robotic control, fluid mechanics and
-
will be based on the collective agreement with the Danish Confederation of Professional Associations. The allowance will be agreed upon with the relevant union. The period of employment is 3 years. DTU
-
defining the T cell immunogenicity of the HLA antigen presented peptides remains very limited. This greatly limits the applicability of current antigen presentation (in-silico and experimental
-
of the rules defining the T cell immunogenicity of the HLA antigen presented peptides remains very limited. This greatly limits the applicability of current antigen presentation (in-silico and